Suppliers · Producer · Discovered — similar established company

Phibro Animal Health

Our story begins with a goal of contributing to a healthy, affordable food supply by helping farmers responsibly care for their animals. With determination and integrity, we have grown into a global company. More than 2,300 employees strong, our team values the trust placed in our products and our people. Our commitment to excellence is demonstrated every day by members of our team, who like to …

active United StatesUSA & Canada Founded 1946 Nasdaq (PAHC)Employees: approximately 2,300 to 2,600 (based on reports of 2,300+ and the addition of 300+ employees from the 2024 acquisition) checked 2026-10-05

Profile

Industry: Cosmetics, Feed, Fishery & aquaculture, Industrial chemistry, Seeds & genetics, Veterinary
Topics: Livestock & poultry production/genetics, Animal feed & feed additives, Shrimp/fish genetics & aquaculture tech
Role: Producer — “…fied company that develops, manufactures, and markets products for food and companion animals, as well as spec…”
Why it is bioeconomy: Phibro Animal Health is a global diversified animal health and mineral nutrition company that develops and markets products for food and companion animals, including vaccines, nutritional specialties, and feed additives.
Found via: [Rubric] United States · animal-vaccines

Bio-solutions it supplies 0

Not yet cited as a supplier in a graded solution.

What they offer

This company does not publish its products or services — we find out through an introduction.

News & status 6

2026-08 Latest status: The company announced the planned closure of its Chicago Heights manufacturing facility in August 2026 as part of a strategic consolidation following its 2024 acquisition of the Zoetis medicated feed additive portfolio. ↗ ↗ ↗
2026-08-27 Phibro Animal Health Posts 17% Sales Growth in Fiscal 2026, Sets 2027 Outlook - Animal Health News
Phibro Animal Health posted strong fiscal 2026 results with 17% net sales growth to $1.52B and notably higher profitability, andGuides fiscal 2027 to about $1.55–$1.60B in sales with solid EBITDA, while strategically consolidating manufacturing by closing the …
2026-08-26 Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance
Phibro Animal Health reported FY2026 results with record net sales of about $1.5B, a 39% year-over-year rise in Adjusted EBITDA to $255M, and provided fiscal 2027 guidance of net sales $1.55–$1.60B, Adjusted EBITDA $258–$268M, and Adjusted net income …
2026-05-05 Phibro Animal Health Corporation Launches Companywide Sustainable Solutions Platform; Introduces VERRATAIN™ Verified Sustainability Solutions Through Strategic VAXA Technologies Partnership
Phibro Animal Health is expanding into sustainability leadership with a new Sustainable Solutions Platform and the Verratain Verified Sustainability Solutions, developed in partnership with VAXA Technologies to deliver low-carbon, microalgae-based feed …
2026-08-27 Latest Company News - Investing.com
Phibro Animal Health delivered a strong fiscal 2026 performance with record net sales, solid profitability gains from Zoetis portfolio integration, and expanding margins across its core animal health business. For fiscal 2027, the company guides modest …
2026-08-31 Phibro (PAHC) Q4 2026 Earnings Call Transcript | The Motley Fool
Phibro Animal Health is undergoing an enterprise-wide transformation (Phibro Forward) to boost margins and cash flow, including consolidating manufacturing, expanding vaccines, and increasing distribution in companion animals, while navigating regulatory …
2026-04-27 Phibro Animal Health Corporation - Phibro Animal Health Corporation Announces Regulatory Framework Change in Brazil for Antimicrobials
Phibro Animal Health announces Brazil will ban certain growth-promoting antimicrobials (virginiamycin and bacitracin) with a 180-day transition; after that, use will require veterinary prescriptions, and Phibro is facilitating compliance via its PhibroVet …

Network: owners, partners, peers

Ownership & investors 1

parent

Independent

Partners & deals 1

counterparty

Zoetis Inc. (medicated feed additive portfolio)

…The company announced the planned closure of its Chicago Heights manufacturing facility in August 2026 as part of a strategic consolidation following its 2024 acquisition of the Zoetis medicated feed ……

Similar companies

Alltech · Neogen Corporation · Fort Dodge Animal Health · FMC Corporation · Corteva Agriscience · Vetoquinol Global · Wilbur-Ellis · ABS Global

Identity & contacts

Contacts, people and legal identity are available to members.